The 10 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 98.00, with a high estimate of 105.00 and a low estimate of 84.00. The median estimate represents a +9.89% increase from the last price of 89.18.
The current consensus among 11 polled investment analysts is to Buy stock in Abbvie Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.25
Reporting Date Apr 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.